期刊文献+

人胰腺癌细胞株HHIP基因甲基化状态检测和分析

Detection and analysis of methylation status of HHIP gene in human pancreatic cancer cell lines
下载PDF
导出
摘要 目的:探讨人胰腺癌细胞株HHIP表达与其甲基化的关系,为胰腺癌发生机制的研究提供新的信息。方法:以人胰腺癌细胞株BxPC-3、CFPAC-1、PANC-1、AsPC-1和PaTu8988s为研究对象,用反转录聚合酶链反应(RT-PCR)及免疫细胞化学染色(S-P)法检测去甲基化制剂——DNA甲基转移酶抑制剂5-氮杂-2′-脱氧胞苷(5-Aza-CdR)处理前后各胰腺癌细胞株HHIPmRNA/蛋白表达的变化,用甲基化特异性PCR(MSP)结合测序检测HHIP基因CpG岛甲基化状态。结果:5-Aza-CdR处理前,胰腺癌细胞株BxPC-3、CFPAC-1、PANC-1、AsPC-1和PaTu8988s无HHIPmRNA/蛋白表达;经5-Aza-CdR处理后,HHIPmRNA/蛋白重新表达。MSP结合测序显示上述胰腺癌细胞株HHIP基因CpG岛存在高甲基化。结论:人胰腺癌细胞株HHIP表达抑制与其基因CpG岛高甲基化相关。HHIP基因CpG岛高甲基化可能在胰腺癌的发生、发展中起一定作用。 Objective:To explore the relationship between HHIP expression and its hypermethylation in human pancreatic cancer cell lines,so as to provide new insights into the tumorigenesis of pancreatic cancer.Methods: Human pancreatic cancer cell lines BxPC-3,CFPAC-1,PANC-1,AsPC-1 and PaTu8988s were used in the present study. Reverse transcriptase polymerase chain reaction(RT-PCR) and immunocytochemical S-P method were used to detect the expression of HHIP at mRNA and protein levels before and after treatment with 5-aza-2′-deoxycytidine (5-Aza-CdR),a DNA methyltransferase inhibitor.Methylation-specific PCR (MSP) combined with DNA sequencing were adopted to identify the CpG island methylation of HHIP gene.Results: Expression of HHIP mRNA/protein was absent in the five pancreatic cancer cell lines before 5-Aza-CdR treatment, and re-expressed after treatment with 5-Aza-CdR.CpG island hypermethylation of HHIP gene was observed in the five pancreatic cell lines by MSP and DNA sequencing.Conclusion: Hypermethylation in CpG island of HHIP gene is correlated with the inhibition of HHIP expression in human pancreatic cancer cell lines, and it might play an important role in the development and progression of pancreatic cancer.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2009年第8期879-883,共5页 Academic Journal of Second Military Medical University
基金 上海市卫生局青年科研项目基金(2007Y85)~~
关键词 胰腺肿瘤 肿瘤细胞系 HHIP基因 DNA甲基化 pancreatic neoplasms tumor cell line HHIP genes DNA methylation
  • 相关文献

参考文献20

  • 1Jemal A, Siegel R, Ward E, Murray T, Xu J, ThunM J. Cancer statistics, 2007[J]. CA Cancer J Clin, 2007,57 : 43-66. 被引量:1
  • 2Rosenberg L. Pancreatic cancer:a review of emerging therapies [J]. Drugs,2000,59: 1071 1089. 被引量:1
  • 3孙罡,王立夫.进展期胰腺癌临床化学治疗进展[J].内科理论与实践,2009,4(1):61-65. 被引量:6
  • 4Dammann R,Schagdarsurengin U, Liu L, Otto N, Gimm O, Dralle H, et al. Frequent RASSFIA promoter hypermethylation and K-ras mutations in pancreatic carcinoma [J]. Oncogene, 2003,22 : 3806-3812. 被引量:1
  • 5Kumagai T,Akagl T, Desmond J C,Kawamata N, Gery S, Imai Y, et al. Epigenetic regulation and molecular characterization of C/EBP alpha in pancreatic cancer cells[J]. Int J Cancer, 2009, 124:827-833. 被引量:1
  • 6Melnikov A A, Seholtens D,Talamonti M S,Bentrem D J, Lev enson V V. Methylation profile of circulating plasma DNA in patients with pancreatic cancer[J]. J Surg Oncol, 2009,99 : 119-122. 被引量:1
  • 7Kayed H,Kleeff J,Keleg S,Guo J,Ketterer K,Berberat P O,et al. Indian hedgehog signaling pathway: expression and regula tion in pancreatic cancer[J]. Int J Cancer, 2004,110 : 868-676. 被引量:1
  • 8Chuang P T, Kaweak T, McMahon A P, Feedback control ot mammalian Hedgehog signaling by the Hedgehog binding protein, Hipl, modulates Fgf signaling during branching morphogenesis of the lung[J]. Genes Dev,2003,17:342-347. 被引量:1
  • 9Martin S T, Sato N, Dhara S, Chang R, Hustinx S R, Abe T, et al. Aberrant Methylation of the Human Hedgehog Interacting Protein (HHIP) Gene in Pancreatic Neoplasms[J]. Cancer Biol Ther, 2005,4 : 728-733. 被引量:1
  • 10Taniguchi H, Yamamoto H, Akutsu N, Nosho K, Adachi Y, Imai K, et al. Transcriptional silencing of hedgehog interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer[J]. J Pathol, 2007,213: 131-139. 被引量:1

二级参考文献3

  • 1Robert L. Fine,David R. Fogelman,Stephen M. Schreibman,Manisha Desai,William Sherman,James Strauss,Susan Guba,Riolan Andrade,John Chabot. The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis[J] 2008,Cancer Chemotherapy and Pharmacology(1):167~175 被引量:1
  • 2Byeong-Bae Park,Joon Oh Park,Hyo Rak Lee,Jeeyun Lee,Dong Wook Choi,Seong-Ho Choi,Jin Seok Heo,Jong Kyun Lee,Kyu Taek Lee,Do Hoon Lim,Young Suk Park,Ho-Yeong Lim,Won Ki Kang,Keunchil Park. A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma[J] 2007,Cancer Chemotherapy and Pharmacology(4):489~494 被引量:1
  • 3V. Heinemann,H. Wilke,H.-G. Mergenthaler,M. Clemens,H. K?nig,H. J. Illiger,M. Arning,A. Schalhorn,K. Possinger,U. Fink. Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer[J] 2000,Annals of Oncology(11):1399~1403 被引量:1

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部